DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Penson RT, Villalobos Valencia R, Cibula D. et al.
Olaparib monotherapy versus (vs) chemotherapy for germline BRCA-mutated (gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase III SOLO3 trial.
J Clin Oncol 2019;
37(15_suppl): 5506
doi:10.1200/jco.2019.37.15_suppl.5506
We do not assume any responsibility for the contents of the web pages of other providers.